Valeo Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,086
| Closed | -$778K | – | 1976 |
|
|
2021
Q1 | $778K | Hold |
5,086
| – | – | 0.04% | 201 |
|
|
2020
Q4 | $795K | Buy |
5,086
+4,316
| +561% | +$675K | 0.04% | 181 |
|
|
2020
Q3 | $88K | Sell |
770
-36
| -4% | -$4.11K | 0.01% | 489 |
|
|
2020
Q2 | $90K | Sell |
806
-364
| -31% | -$40.6K | 0.01% | 515 |
|
|
2020
Q1 | $114K | Hold |
1,170
| – | – | 0.01% | 391 |
|
|
2019
Q4 | $127K | Buy |
1,170
+500
| +75% | +$54.3K | 0.01% | 408 |
|
|
2019
Q3 | $66K | Sell |
670
-600
| -47% | -$59.1K | 0.01% | 523 |
|
|
2019
Q2 | $166K | Buy |
1,270
+595
| +88% | +$77.8K | 0.02% | 321 |
|
|
2019
Q1 | $91K | Buy |
675
+198
| +42% | +$26.7K | 0.01% | 428 |
|
|
2018
Q4 | $46K | Sell |
477
-208
| -30% | -$20.1K | 0.01% | 514 |
|
|
2018
Q3 | $77K | Sell |
685
-108
| -14% | -$12.1K | 0.01% | 463 |
|
|
2018
Q2 | $94K | Sell |
793
-285
| -26% | -$33.8K | 0.01% | 407 |
|
|
2018
Q1 | $120K | Hold |
1,078
| – | – | 0.02% | 330 |
|
|
2017
Q4 | $129K | Buy |
1,078
+33
| +3% | +$3.95K | 0.02% | 297 |
|
|
2017
Q3 | $147K | Buy |
+1,045
| New | +$147K | 0.03% | 234 |
|